Timber, Amedisys top healthcare gainers; Bellerophon, Castle among losers
Seeking Alpha · 1d ago
Connect Biopharma, LAVA top healthcare gainers; Kiora, Kymera among losers
Seeking Alpha · 4d ago
XPEV, MDB and IQ are among pre market gainers
Seeking Alpha · 4d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 5d ago
Nanobiotix, Veeva top healthcare gainers; Lexicon, Adicet among losers
Seeking Alpha · 5d ago
Despite Fast-paced Momentum, Rockwell Medical (RMTI) Is Still a Bargain Stock
NASDAQ · 5d ago
HC Wainwright & Co. Maintains Rockwell Medical (RMTI) Buy Recommendation
NASDAQ · 05/30 15:20
H.C. Wainwright Remains a Buy on Rockwell Med (RMTI)
TipRanks · 05/30 10:15
HC Wainwright & Co. Maintains Buy on Rockwell Medical, Raises Price Target to $9
Benzinga · 05/30 10:11
Rockwell Medical: Buy This Undervalued Growth Story
Seeking Alpha · 05/30 09:14
--HC Wainwright Adjusts Price Target on Rockwell Medical to $9 From $7, Keeps Buy Rating
--HC Wainwright Adjusts Price Target on Rockwell Medical to $9 From $7, Keeps Buy Rating
MT Newswires · 05/30 09:05
Rockwell Med Inc: Statement of changes in beneficial ownership of securities
Press release · 05/25 21:12
SNDL, Invitae among additions to Russell microcap; Inovio, Bionano among deletions
Seeking Alpha · 05/24 17:33
Rockwell Med Inc: Current report
Press release · 05/24 00:15
Rockwell Medical Clocks 22% Growth In Q1 Revenues, Seeks Profitability
Benzinga · 05/15 14:09
Webull provides a variety of real-time RMTI stock news. You can receive the latest news about Rockwell Med Inc through multiple platforms. This information may help you make smarter investment decisions.
About RMTI
Rockwell Medical, Inc. is a commercial healthcare company. The Company is focused on providing products for patients suffering from blood disorders and diseases associated with the kidney. It is developing and commercializing its technology platform, Ferric Pyrophosphate Citrate (FPC) for the transformative treatments for iron deficiency in multiple disease states. It is also a supplier of hemodialysis concentrate products to kidney dialysis clinics. The Company has developed therapies namely Triferic and Triferic AVNU from its FPC platform. Its products Triferic (dialysate) and Triferic AVNU intravenous (IV), is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients. Its Triferic AVNU, is an IV formulation of Triferic, for use by hemodialysis patients. The Company’s dialysis concentrates products include CitraPure Citric Acid Concentrate, RenalPure Liquid Acid Concentrate, RenalPure and SteriLyte Bicarbonate Concentrate and Ancillary products.